MarketPulse

preclinical milestone

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Cue Biopharma Secures $7.5M Milestone from Boehringer Ingelheim Deal

$CBPO secures $7.5M milestone from Boehringer Ingelheim partnership, with $337.5M upside potential as lead compound advances to optimization.
CUEautoimmune diseasesbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Curanex Advances Phyto-N Toward Late-Stage Development as Clinical Timeline Solidifies

Curanex advances Phyto-N toward IND submission in Q4 2026, completing manufacturing and toxicology milestones with secured 12-month funding.
CURXclinical trialspharmaceutical development